255 related articles for article (PubMed ID: 11514714)
1. A novel method using baculovirus-mediated gene transfer for production of recombinant adeno-associated virus vectors.
Sollerbrant K; Elmén J; Wahlestedt C; Acker J; Leblois-Prehaud H; Latta-Mahieu M; Yeh P; Perricaudet M
J Gen Virol; 2001 Sep; 82(Pt 9):2051-2060. PubMed ID: 11514714
[TBL] [Abstract][Full Text] [Related]
2. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
[TBL] [Abstract][Full Text] [Related]
3. Insect cells as a factory to produce adeno-associated virus type 2 vectors.
Urabe M; Ding C; Kotin RM
Hum Gene Ther; 2002 Nov; 13(16):1935-43. PubMed ID: 12427305
[TBL] [Abstract][Full Text] [Related]
4. Combination of baculovirus-mediated gene delivery and packed-bed reactor for scalable production of adeno-associated virus.
Huang KS; Lo WH; Chung YC; Lai YK; Chen CY; Chou ST; Hu YC
Hum Gene Ther; 2007 Nov; 18(11):1161-70. PubMed ID: 17944574
[TBL] [Abstract][Full Text] [Related]
5. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
6. A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells.
Smith RH; Levy JR; Kotin RM
Mol Ther; 2009 Nov; 17(11):1888-96. PubMed ID: 19532142
[TBL] [Abstract][Full Text] [Related]
7. Impact of Inverted Terminal Repeat Integrity on rAAV8 Production Using the Baculovirus/Sf9 Cells System.
Savy A; Dickx Y; Nauwynck L; Bonnin D; Merten OW; Galibert L
Hum Gene Ther Methods; 2017 Oct; 28(5):277-289. PubMed ID: 28967288
[TBL] [Abstract][Full Text] [Related]
8. Transposase-mediated construction of an integrated adeno-associated virus type 5 helper plasmid.
Smith RH; Afione SA; Kotin RM
Biotechniques; 2002 Jul; 33(1):204-6, 208, 210-1. PubMed ID: 12139247
[TBL] [Abstract][Full Text] [Related]
9. Development of Versatile and Flexible Sf9 Packaging Cell Line-Dependent OneBac System for Large-Scale Recombinant Adeno-Associated Virus Production.
Wu Y; Mei T; Jiang L; Han Z; Dong R; Yang T; Xu F
Hum Gene Ther Methods; 2019 Oct; 30(5):172-183. PubMed ID: 31566024
[TBL] [Abstract][Full Text] [Related]
10. Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector.
Palombo F; Monciotti A; Recchia A; Cortese R; Ciliberto G; La Monica N
J Virol; 1998 Jun; 72(6):5025-34. PubMed ID: 9573272
[TBL] [Abstract][Full Text] [Related]
11. Genetics instability of wtAAV2 genome and AAV promoter activities in the Baculovirus/Sf9 cells system.
Savy A; Kaikkonen MU; Léger A; Dickx Y; Galibert L; Merten OW
PLoS One; 2018; 13(7):e0199866. PubMed ID: 29975713
[TBL] [Abstract][Full Text] [Related]
12. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
[TBL] [Abstract][Full Text] [Related]
13. Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV.
Fan PD; Dong JY
Hum Gene Ther; 1997 Jan; 8(1):87-98. PubMed ID: 8989998
[TBL] [Abstract][Full Text] [Related]
14. Homologous Recombination Offers Advantages over Transposition-Based Systems to Generate Recombinant Baculovirus for Adeno-Associated Viral Vector Production.
Jacob A; Brun L; Jiménez Gil P; Ménard L; Bouzelha M; Broucque F; Roblin A; Vandenberghe LH; Adjali O; Robin C; François A; Blouin V; Penaud-Budloo M; Ayuso E
Biotechnol J; 2021 Jan; 16(1):e2000014. PubMed ID: 33067902
[TBL] [Abstract][Full Text] [Related]
15. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
[TBL] [Abstract][Full Text] [Related]
16. A helper virus-free packaging system for recombinant adeno-associated virus vectors.
Collaco RF; Cao X; Trempe JP
Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing recombinant adeno-associated virus production.
Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
[TBL] [Abstract][Full Text] [Related]
18. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.
Lieber A; Steinwaerder DS; Carlson CA; Kay MA
J Virol; 1999 Nov; 73(11):9314-24. PubMed ID: 10516040
[TBL] [Abstract][Full Text] [Related]
19. Novel tools for production and purification of recombinant adenoassociated virus vectors.
Grimm D; Kern A; Rittner K; Kleinschmidt JA
Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
[TBL] [Abstract][Full Text] [Related]
20. OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy.
Mietzsch M; Grasse S; Zurawski C; Weger S; Bennett A; Agbandje-McKenna M; Muzyczka N; Zolotukhin S; Heilbronn R
Hum Gene Ther; 2014 Mar; 25(3):212-22. PubMed ID: 24299301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
